Therapeutic Advances in Psychopharmacology
Impact Factor: 4
Editor-In-Chief: David Taylor
Sub-Specialty: Clinical Medicine, Surgery
Discipline: Pharmacology, Toxicology
Description:
Please see the Aims and Scope for further information. The journal is a member of the Committee on Publication Ethics (COPE). Diversity, Equity and Inclusion Statement. Therapeutic Advances in Psychopharmacology (TPP) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the psychopharmacology community. Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
Link To Journal
Sage Media Kit
Contact Our Sales Team